Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis Reporter: Larry Bernstein, MD This is an overview of a recently published article about a new treatment for ulcerative colitis. It also reviews the use of a class of drug in inflammatory conditions, and introduces the problem of sepsis. Tofacitinib, an Oral Janus Kinase Inhibitor, … Continue reading Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis